Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Mar 4, 2014

29777_dirs_2014-03-04_1195b2fb-54e4-4228-a452-ad04b691b9ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-28

Reporting Person: Funck Robert E (Vice President, Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 Common shares without par value F 3129 $39.79 Disposed 64339 Direct
2014-03-03 Common shares without par value S 713 $38.9710 Disposed 63626 Direct
2014-03-03 Common shares without par value S 700 $38.9740 Disposed 62926 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 15562 Indirect
Common shares without par value 500 Indirect
Common shares without par value 500 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.